{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:32:01Z","timestamp":1790951521129,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>Hereditary cancer syndromes associated with gynecologic malignancies account for up to 18% of all cases of ovarian, uterine, and cervical cancers, and identification of these syndromes has implications for cancer screening and risk reduction techniques in affected patients. The associated cancer risks with moderate-penetrance genes are rapidly evolving and present variable risks for the provider counseling the patient. In this review, we detail the cancer risk and management of patients with germline PV in the moderate-risk hereditary cancer genes <jats:italic toggle=\"yes\">ATM<\/jats:italic>, <jats:italic toggle=\"yes\">BRIP1<\/jats:italic>, <jats:italic toggle=\"yes\">RAD51C<\/jats:italic>, <jats:italic toggle=\"yes\">RAD51D<\/jats:italic>, and <jats:italic toggle=\"yes\">PALB2<\/jats:italic>.<\/jats:p>","DOI":"10.1097\/grf.0000000000000897","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T14:06:55Z","timestamp":1727359615000},"page":"696-701","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["What About the Others? Clinical Management of Gynecologic Cancer Risk in Patients With Moderate-Risk Hereditary Cancer Genes (ATM, BRIP1, RAD51C, RAD51D, and PALB2)"],"prefix":"10.1097","volume":"67","author":[{"given":"Ester I.","family":"Goldfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna E.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari L.","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2019.06.017","article-title":"Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review","volume":"155","author":"Chen","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R2-20250512","first-page":"573","article-title":"The incidence and gene frequency of ataxia-telangiectasia in the United States","volume":"39","author":"Swift","year":"1986","journal-title":"Am J Hum Genet"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1158\/1940-6207.CAPR-20-0448","article-title":"Germline pathogenic variants in the ataxia telangiectasia mutated (ATM) gene are associated with high and moderate risks for multiple cancers","volume":"14","author":"Hall","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2017.08.030","article-title":"Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls","volume":"147","author":"Lilyquist","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cancergen.2022.03.003","article-title":"Functional analysis of ATM variants in a high risk cohort provides insight into missing heritability","volume":"264-265","author":"Baughan","year":"2022","journal-title":"Cancer Genet"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1200\/OP.21.00382","article-title":"Risk-reducing bilateral salpingo-oophorectomy for ovarian cancer: a review and clinical guide for hereditary predisposition genes","volume":"18","author":"Liu","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2015.10.001","article-title":"Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women","volume":"139","author":"Manchanda","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/jmedgenet-2016-103800","article-title":"Specifying the ovarian cancer risk threshold of \u2018premenopausal risk-reducing salpingo-oophorectomy\u2019 for ovarian cancer prevention: a cost-effectiveness analysis","volume":"53","author":"Manchanda","year":"2016","journal-title":"J Med Genet"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/igc.0000000000001147","article-title":"Setting the threshold for surgical prevention in women at increased risk of ovarian cancer","volume":"28","author":"Manchanda","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"e1011175","DOI":"10.1371\/journal.pgen.1011175","article-title":"The DNA helicase FANCJ (BRIP1) functions in double strand break repair processing, but not crossover formation during prophase I of meiosis in male mice","volume":"20","author":"Horan","year":"2024","journal-title":"PLoS Genet"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-genet-102108-134222","article-title":"How the fanconi anemia pathway guards the genome","volume":"43","author":"Moldovan","year":"2009","journal-title":"Annu Rev Genet"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.955","article-title":"Mutations in BRIP1 confer high risk of ovarian cancer","volume":"43","author":"Rafnar","year":"2011","journal-title":"Nat Genet"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"djv214","DOI":"10.1093\/jnci\/djv214","article-title":"Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer.","volume":"107","author":"Ramus","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2019.01.027","article-title":"Large-scale meta-analysis of mutations identified in panels of breast\/ovarian cancer-related genes\u2014providing evidence of cancer predisposition genes","volume":"153","author":"Suszynska","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13048-021-00809-w","article-title":"Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing","volume":"14","author":"Cummings","year":"2021","journal-title":"J Ovarian Res"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13048-020-00654-3","article-title":"BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases","volume":"13","author":"Suszynska","year":"2020","journal-title":"J Ovarian Res"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/cncr.34331","article-title":"Further refining 2020 ESGO\/ESTRO\/ESP molecular risk classes in patients with early-stage endometrial cancer: a propensity score-matched analysis","volume":"128","author":"Nero","year":"2022","journal-title":"Cancer"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/MCB.00465-12","article-title":"Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway","volume":"33","author":"Chun","year":"2013","journal-title":"Mol Cell Biol"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ng.2224","article-title":"Germline RAD51C mutations confer susceptibility to ovarian cancer","volume":"44","author":"Loveday","year":"2012","journal-title":"Nat Genet"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1200\/JCO.2015.61.2408","article-title":"Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population","volume":"33","author":"Song","year":"2015","journal-title":"J Clin Oncol"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/jnci\/djaa030","article-title":"Ovarian and breast cancer risks associated with pathogenic variants in RAD51C and RAD51D","volume":"112","author":"Yang","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"R25-20250512","doi-asserted-by":"crossref","first-page":"e216744","DOI":"10.1001\/jamaoncol.2021.6744","article-title":"Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes","volume":"8","author":"Mavaddat","year":"2022","journal-title":"JAMA Oncol"},{"key":"R26-20250512","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1200\/JCO.2016.69.9330","article-title":"Evidence of stage shift in women diagnosed with ovarian cancer during phase II of the United Kingdom familial ovarian cancer screening study","volume":"35","author":"Rosenthal","year":"2017","journal-title":"J Clin Oncol"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jmedgenet-2012-100852","article-title":"A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer","volume":"49","author":"Pelttari","year":"2012","journal-title":"J Med Genet"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R29-20250512","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41436-021-01151-8","article-title":"Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Tischkowitz","year":"2021","journal-title":"Genet Med"},{"key":"R30-20250512","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.3390\/cells9122675","article-title":"CHEK2 germline variants in cancer predisposition: stalemate rather than checkmate","volume":"9","author":"Stolarova","year":"2020","journal-title":"Cells"},{"key":"R31-20250512","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1158\/1078-0432.CCR-15-2750","article-title":"Early detection of ovarian cancer using the risk of ovarian cancer algorithm with frequent CA125 testing in women at increased familial risk\u2014combined results from two screening trials","volume":"23","author":"Skates","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R32-20250512","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women\u2019s Health Initiative Randomized Trials","volume":"318","author":"Manson","year":"2017","journal-title":"JAMA"},{"key":"R33-20250512","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/AOG.0000000000004732","article-title":"A revised Markov model evaluating oophorectomy at the time of hysterectomy for benign indication: age 65 years revisited","volume":"139","author":"Rush","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R34-20250512","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2023.03.017","article-title":"Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and Lynch syndrome ovarian cancer susceptibility genes","volume":"173","author":"Schwartz","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R35-20250512","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajog.2013.04.019","article-title":"The role of the fallopian tube in the origin of ovarian cancer","volume":"209","author":"Erickson","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R36-20250512","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamasurg.2023.4164","article-title":"Salpingectomy for the primary prevention of ovarian cancer: a systematic review","volume":"158","author":"Kahn","year":"2023","journal-title":"JAMA Surg"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:07:55Z","timestamp":1747062475000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000897","relation":{},"ISSN":["0009-9201","1532-5520"],"issn-type":[{"value":"0009-9201","type":"print"},{"value":"1532-5520","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}